Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Nuclear Receptor ROR Gamma Market Growth 2022-2028

  • LP 4928590
  • 111 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Nuclear Receptor ROR Gamma will have significant change from previous year. According to our (LP Information) latest study, the global Nuclear Receptor ROR Gamma market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Nuclear Receptor ROR Gamma market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Nuclear Receptor ROR Gamma market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Nuclear Receptor ROR Gamma market, reaching US$ million by the year 2028. As for the Europe Nuclear Receptor ROR Gamma landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Nuclear Receptor ROR Gamma players cover Genfit SA, GlaxoSmithKline Plc, Aurigene Discovery Technologies, and Beijing Hanmi Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Receptor ROR Gamma market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

BBI-6000

GRC-39815Action

R&D Progress

GSK-2981278

IMU-366

INV-17

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Chronic Obstructive Pulmonary Disease

Asthma

Axial Spondyloarthritis

Breast Cancer

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Genfit SA

GlaxoSmithKline Plc

Aurigene Discovery Technologies

Beijing Hanmi Pharmaceutical

Biogen Inc

AbbVie Inc

Eurofins Advinus

Brickell Biotech Inc

Pfizer Inc

Phenex Pharmaceuticals AG

Reata Pharmaceuticals Inc

Bristol-Myers Squibb Company

Celgene Corp

Eli Lilly

Glenmark Pharmaceuticals

Lead Pharma Holding BV

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Nuclear Receptor ROR Gamma Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Nuclear Receptor ROR Gamma by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Nuclear Receptor ROR Gamma by Country/Region, 2017, 2022 & 2028

2.2 Nuclear Receptor ROR Gamma Segment by Type

2.2.1 BBI-6000

2.2.2 GRC-39815Action

2.2.3 R&D Progress

2.2.4 GSK-2981278

2.2.5 IMU-366

2.2.6 INV-17

2.2.7 Others

2.3 Nuclear Receptor ROR Gamma Sales by Type

2.3.1 Global Nuclear Receptor ROR Gamma Sales Market Share by Type (2017-2022)

2.3.2 Global Nuclear Receptor ROR Gamma Revenue and Market Share by Type (2017-2022)

2.3.3 Global Nuclear Receptor ROR Gamma Sale Price by Type (2017-2022)

2.4 Nuclear Receptor ROR Gamma Segment by Application

2.4.1 Chronic Obstructive Pulmonary Disease

2.4.2 Asthma

2.4.3 Axial Spondyloarthritis

2.4.4 Breast Cancer

2.4.5 Others

2.5 Nuclear Receptor ROR Gamma Sales by Application

2.5.1 Global Nuclear Receptor ROR Gamma Sale Market Share by Application (2017-2022)

2.5.2 Global Nuclear Receptor ROR Gamma Revenue and Market Share by Application (2017-2022)

2.5.3 Global Nuclear Receptor ROR Gamma Sale Price by Application (2017-2022)

3 Global Nuclear Receptor ROR Gamma by Company

3.1 Global Nuclear Receptor ROR Gamma Breakdown Data by Company

3.1.1 Global Nuclear Receptor ROR Gamma Annual Sales by Company (2020-2022)

3.1.2 Global Nuclear Receptor ROR Gamma Sales Market Share by Company (2020-2022)

3.2 Global Nuclear Receptor ROR Gamma Annual Revenue by Company (2020-2022)

3.2.1 Global Nuclear Receptor ROR Gamma Revenue by Company (2020-2022)

3.2.2 Global Nuclear Receptor ROR Gamma Revenue Market Share by Company (2020-2022)

3.3 Global Nuclear Receptor ROR Gamma Sale Price by Company

3.4 Key Manufacturers Nuclear Receptor ROR Gamma Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Nuclear Receptor ROR Gamma Product Location Distribution

3.4.2 Players Nuclear Receptor ROR Gamma Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Nuclear Receptor ROR Gamma by Geographic Region

4.1 World Historic Nuclear Receptor ROR Gamma Market Size by Geographic Region (2017-2022)

4.1.1 Global Nuclear Receptor ROR Gamma Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Nuclear Receptor ROR Gamma Annual Revenue by Geographic Region

4.2 World Historic Nuclear Receptor ROR Gamma Market Size by Country/Region (2017-2022)

4.2.1 Global Nuclear Receptor ROR Gamma Annual Sales by Country/Region (2017-2022)

4.2.2 Global Nuclear Receptor ROR Gamma Annual Revenue by Country/Region

4.3 Americas Nuclear Receptor ROR Gamma Sales Growth

4.4 APAC Nuclear Receptor ROR Gamma Sales Growth

4.5 Europe Nuclear Receptor ROR Gamma Sales Growth

4.6 Middle East & Africa Nuclear Receptor ROR Gamma Sales Growth

5 Americas

5.1 Americas Nuclear Receptor ROR Gamma Sales by Country

5.1.1 Americas Nuclear Receptor ROR Gamma Sales by Country (2017-2022)

5.1.2 Americas Nuclear Receptor ROR Gamma Revenue by Country (2017-2022)

5.2 Americas Nuclear Receptor ROR Gamma Sales by Type

5.3 Americas Nuclear Receptor ROR Gamma Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Nuclear Receptor ROR Gamma Sales by Region

6.1.1 APAC Nuclear Receptor ROR Gamma Sales by Region (2017-2022)

6.1.2 APAC Nuclear Receptor ROR Gamma Revenue by Region (2017-2022)

6.2 APAC Nuclear Receptor ROR Gamma Sales by Type

6.3 APAC Nuclear Receptor ROR Gamma Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Nuclear Receptor ROR Gamma by Country

7.1.1 Europe Nuclear Receptor ROR Gamma Sales by Country (2017-2022)

7.1.2 Europe Nuclear Receptor ROR Gamma Revenue by Country (2017-2022)

7.2 Europe Nuclear Receptor ROR Gamma Sales by Type

7.3 Europe Nuclear Receptor ROR Gamma Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Nuclear Receptor ROR Gamma by Country

8.1.1 Middle East & Africa Nuclear Receptor ROR Gamma Sales by Country (2017-2022)

8.1.2 Middle East & Africa Nuclear Receptor ROR Gamma Revenue by Country (2017-2022)

8.2 Middle East & Africa Nuclear Receptor ROR Gamma Sales by Type

8.3 Middle East & Africa Nuclear Receptor ROR Gamma Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Nuclear Receptor ROR Gamma

10.3 Manufacturing Process Analysis of Nuclear Receptor ROR Gamma

10.4 Industry Chain Structure of Nuclear Receptor ROR Gamma

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Nuclear Receptor ROR Gamma Distributors

11.3 Nuclear Receptor ROR Gamma Customer

12 World Forecast Review for Nuclear Receptor ROR Gamma by Geographic Region

12.1 Global Nuclear Receptor ROR Gamma Market Size Forecast by Region

12.1.1 Global Nuclear Receptor ROR Gamma Forecast by Region (2023-2028)

12.1.2 Global Nuclear Receptor ROR Gamma Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Nuclear Receptor ROR Gamma Forecast by Type

12.7 Global Nuclear Receptor ROR Gamma Forecast by Application

13 Key Players Analysis

13.1 Genfit SA

13.1.1 Genfit SA Company Information

13.1.2 Genfit SA Nuclear Receptor ROR Gamma Product Offered

13.1.3 Genfit SA Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Genfit SA Main Business Overview

13.1.5 Genfit SA Latest Developments

13.2 GlaxoSmithKline Plc

13.2.1 GlaxoSmithKline Plc Company Information

13.2.2 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Product Offered

13.2.3 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GlaxoSmithKline Plc Main Business Overview

13.2.5 GlaxoSmithKline Plc Latest Developments

13.3 Aurigene Discovery Technologies

13.3.1 Aurigene Discovery Technologies Company Information

13.3.2 Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Product Offered

13.3.3 Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Aurigene Discovery Technologies Main Business Overview

13.3.5 Aurigene Discovery Technologies Latest Developments

13.4 Beijing Hanmi Pharmaceutical

13.4.1 Beijing Hanmi Pharmaceutical Company Information

13.4.2 Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Product Offered

13.4.3 Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Beijing Hanmi Pharmaceutical Main Business Overview

13.4.5 Beijing Hanmi Pharmaceutical Latest Developments

13.5 Biogen Inc

13.5.1 Biogen Inc Company Information

13.5.2 Biogen Inc Nuclear Receptor ROR Gamma Product Offered

13.5.3 Biogen Inc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Biogen Inc Main Business Overview

13.5.5 Biogen Inc Latest Developments

13.6 AbbVie Inc

13.6.1 AbbVie Inc Company Information

13.6.2 AbbVie Inc Nuclear Receptor ROR Gamma Product Offered

13.6.3 AbbVie Inc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 AbbVie Inc Main Business Overview

13.6.5 AbbVie Inc Latest Developments

13.7 Eurofins Advinus

13.7.1 Eurofins Advinus Company Information

13.7.2 Eurofins Advinus Nuclear Receptor ROR Gamma Product Offered

13.7.3 Eurofins Advinus Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Eurofins Advinus Main Business Overview

13.7.5 Eurofins Advinus Latest Developments

13.8 Brickell Biotech Inc

13.8.1 Brickell Biotech Inc Company Information

13.8.2 Brickell Biotech Inc Nuclear Receptor ROR Gamma Product Offered

13.8.3 Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Brickell Biotech Inc Main Business Overview

13.8.5 Brickell Biotech Inc Latest Developments

13.9 Pfizer Inc

13.9.1 Pfizer Inc Company Information

13.9.2 Pfizer Inc Nuclear Receptor ROR Gamma Product Offered

13.9.3 Pfizer Inc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Pfizer Inc Main Business Overview

13.9.5 Pfizer Inc Latest Developments

13.10 Phenex Pharmaceuticals AG

13.10.1 Phenex Pharmaceuticals AG Company Information

13.10.2 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Product Offered

13.10.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Phenex Pharmaceuticals AG Main Business Overview

13.10.5 Phenex Pharmaceuticals AG Latest Developments

13.11 Reata Pharmaceuticals Inc

13.11.1 Reata Pharmaceuticals Inc Company Information

13.11.2 Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Product Offered

13.11.3 Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Reata Pharmaceuticals Inc Main Business Overview

13.11.5 Reata Pharmaceuticals Inc Latest Developments

13.12 Bristol-Myers Squibb Company

13.12.1 Bristol-Myers Squibb Company Company Information

13.12.2 Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Product Offered

13.12.3 Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Bristol-Myers Squibb Company Main Business Overview

13.12.5 Bristol-Myers Squibb Company Latest Developments

13.13 Celgene Corp

13.13.1 Celgene Corp Company Information

13.13.2 Celgene Corp Nuclear Receptor ROR Gamma Product Offered

13.13.3 Celgene Corp Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Celgene Corp Main Business Overview

13.13.5 Celgene Corp Latest Developments

13.14 Eli Lilly

13.14.1 Eli Lilly Company Information

13.14.2 Eli Lilly Nuclear Receptor ROR Gamma Product Offered

13.14.3 Eli Lilly Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Eli Lilly Main Business Overview

13.14.5 Eli Lilly Latest Developments

13.15 Glenmark Pharmaceuticals

13.15.1 Glenmark Pharmaceuticals Company Information

13.15.2 Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Product Offered

13.15.3 Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Glenmark Pharmaceuticals Main Business Overview

13.15.5 Glenmark Pharmaceuticals Latest Developments

13.16 Lead Pharma Holding BV

13.16.1 Lead Pharma Holding BV Company Information

13.16.2 Lead Pharma Holding BV Nuclear Receptor ROR Gamma Product Offered

13.16.3 Lead Pharma Holding BV Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Lead Pharma Holding BV Main Business Overview

13.16.5 Lead Pharma Holding BV Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Nuclear Receptor ROR Gamma Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Nuclear Receptor ROR Gamma Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of BBI-6000

Table 4. Major Players of GRC-39815Action

Table 5. Major Players of R&D Progress

Table 6. Major Players of GSK-2981278

Table 7. Major Players of IMU-366

Table 8. Major Players of INV-17

Table 9. Major Players of Others

Table 10. Global Nuclear Receptor ROR Gamma Sales by Type (2017-2022) & (K Pcs)

Table 11. Global Nuclear Receptor ROR Gamma Sales Market Share by Type (2017-2022)

Table 12. Global Nuclear Receptor ROR Gamma Revenue by Type (2017-2022) & ($ million)

Table 13. Global Nuclear Receptor ROR Gamma Revenue Market Share by Type (2017-2022)

Table 14. Global Nuclear Receptor ROR Gamma Sale Price by Type (2017-2022) & (USD/Pcs)

Table 15. Global Nuclear Receptor ROR Gamma Sales by Application (2017-2022) & (K Pcs)

Table 16. Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2017-2022)

Table 17. Global Nuclear Receptor ROR Gamma Revenue by Application (2017-2022)

Table 18. Global Nuclear Receptor ROR Gamma Revenue Market Share by Application (2017-2022)

Table 19. Global Nuclear Receptor ROR Gamma Sale Price by Application (2017-2022) & (USD/Pcs)

Table 20. Global Nuclear Receptor ROR Gamma Sales by Company (2020-2022) & (K Pcs)

Table 21. Global Nuclear Receptor ROR Gamma Sales Market Share by Company (2020-2022)

Table 22. Global Nuclear Receptor ROR Gamma Revenue by Company (2020-2022) ($ Millions)

Table 23. Global Nuclear Receptor ROR Gamma Revenue Market Share by Company (2020-2022)

Table 24. Global Nuclear Receptor ROR Gamma Sale Price by Company (2020-2022) & (USD/Pcs)

Table 25. Key Manufacturers Nuclear Receptor ROR Gamma Producing Area Distribution and Sales Area

Table 26. Players Nuclear Receptor ROR Gamma Products Offered

Table 27. Nuclear Receptor ROR Gamma Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 28. New Products and Potential Entrants

Table 29. Mergers & Acquisitions, Expansion

Table 30. Global Nuclear Receptor ROR Gamma Sales by Geographic Region (2017-2022) & (K Pcs)

Table 31. Global Nuclear Receptor ROR Gamma Sales Market Share Geographic Region (2017-2022)

Table 32. Global Nuclear Receptor ROR Gamma Revenue by Geographic Region (2017-2022) & ($ millions)

Table 33. Global Nuclear Receptor ROR Gamma Revenue Market Share by Geographic Region (2017-2022)

Table 34. Global Nuclear Receptor ROR Gamma Sales by Country/Region (2017-2022) & (K Pcs)

Table 35. Global Nuclear Receptor ROR Gamma Sales Market Share by Country/Region (2017-2022)

Table 36. Global Nuclear Receptor ROR Gamma Revenue by Country/Region (2017-2022) & ($ millions)

Table 37. Global Nuclear Receptor ROR Gamma Revenue Market Share by Country/Region (2017-2022)

Table 38. Americas Nuclear Receptor ROR Gamma Sales by Country (2017-2022) & (K Pcs)

Table 39. Americas Nuclear Receptor ROR Gamma Sales Market Share by Country (2017-2022)

Table 40. Americas Nuclear Receptor ROR Gamma Revenue by Country (2017-2022) & ($ Millions)

Table 41. Americas Nuclear Receptor ROR Gamma Revenue Market Share by Country (2017-2022)

Table 42. Americas Nuclear Receptor ROR Gamma Sales by Type (2017-2022) & (K Pcs)

Table 43. Americas Nuclear Receptor ROR Gamma Sales Market Share by Type (2017-2022)

Table 44. Americas Nuclear Receptor ROR Gamma Sales by Application (2017-2022) & (K Pcs)

Table 45. Americas Nuclear Receptor ROR Gamma Sales Market Share by Application (2017-2022)

Table 46. APAC Nuclear Receptor ROR Gamma Sales by Region (2017-2022) & (K Pcs)

Table 47. APAC Nuclear Receptor ROR Gamma Sales Market Share by Region (2017-2022)

Table 48. APAC Nuclear Receptor ROR Gamma Revenue by Region (2017-2022) & ($ Millions)

Table 49. APAC Nuclear Receptor ROR Gamma Revenue Market Share by Region (2017-2022)

Table 50. APAC Nuclear Receptor ROR Gamma Sales by Type (2017-2022) & (K Pcs)

Table 51. APAC Nuclear Receptor ROR Gamma Sales Market Share by Type (2017-2022)

Table 52. APAC Nuclear Receptor ROR Gamma Sales by Application (2017-2022) & (K Pcs)

Table 53. APAC Nuclear Receptor ROR Gamma Sales Market Share by Application (2017-2022)

Table 54. Europe Nuclear Receptor ROR Gamma Sales by Country (2017-2022) & (K Pcs)

Table 55. Europe Nuclear Receptor ROR Gamma Sales Market Share by Country (2017-2022)

Table 56. Europe Nuclear Receptor ROR Gamma Revenue by Country (2017-2022) & ($ Millions)

Table 57. Europe Nuclear Receptor ROR Gamma Revenue Market Share by Country (2017-2022)

Table 58. Europe Nuclear Receptor ROR Gamma Sales by Type (2017-2022) & (K Pcs)

Table 59. Europe Nuclear Receptor ROR Gamma Sales Market Share by Type (2017-2022)

Table 60. Europe Nuclear Receptor ROR Gamma Sales by Application (2017-2022) & (K Pcs)

Table 61. Europe Nuclear Receptor ROR Gamma Sales Market Share by Application (2017-2022)

Table 62. Middle East & Africa Nuclear Receptor ROR Gamma Sales by Country (2017-2022) & (K Pcs)

Table 63. Middle East & Africa Nuclear Receptor ROR Gamma Sales Market Share by Country (2017-2022)

Table 64. Middle East & Africa Nuclear Receptor ROR Gamma Revenue by Country (2017-2022) & ($ Millions)

Table 65. Middle East & Africa Nuclear Receptor ROR Gamma Revenue Market Share by Country (2017-2022)

Table 66. Middle East & Africa Nuclear Receptor ROR Gamma Sales by Type (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Nuclear Receptor ROR Gamma Sales Market Share by Type (2017-2022)

Table 68. Middle East & Africa Nuclear Receptor ROR Gamma Sales by Application (2017-2022) & (K Pcs)

Table 69. Middle East & Africa Nuclear Receptor ROR Gamma Sales Market Share by Application (2017-2022)

Table 70. Key Market Drivers & Growth Opportunities of Nuclear Receptor ROR Gamma

Table 71. Key Market Challenges & Risks of Nuclear Receptor ROR Gamma

Table 72. Key Industry Trends of Nuclear Receptor ROR Gamma

Table 73. Nuclear Receptor ROR Gamma Raw Material

Table 74. Key Suppliers of Raw Materials

Table 75. Nuclear Receptor ROR Gamma Distributors List

Table 76. Nuclear Receptor ROR Gamma Customer List

Table 77. Global Nuclear Receptor ROR Gamma Sales Forecast by Region (2023-2028) & (K Pcs)

Table 78. Global Nuclear Receptor ROR Gamma Sales Market Forecast by Region

Table 79. Global Nuclear Receptor ROR Gamma Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Global Nuclear Receptor ROR Gamma Revenue Market Share Forecast by Region (2023-2028)

Table 81. Americas Nuclear Receptor ROR Gamma Sales Forecast by Country (2023-2028) & (K Pcs)

Table 82. Americas Nuclear Receptor ROR Gamma Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. APAC Nuclear Receptor ROR Gamma Sales Forecast by Region (2023-2028) & (K Pcs)

Table 84. APAC Nuclear Receptor ROR Gamma Revenue Forecast by Region (2023-2028) & ($ millions)

Table 85. Europe Nuclear Receptor ROR Gamma Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Europe Nuclear Receptor ROR Gamma Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Middle East & Africa Nuclear Receptor ROR Gamma Sales Forecast by Country (2023-2028) & (K Pcs)

Table 88. Middle East & Africa Nuclear Receptor ROR Gamma Revenue Forecast by Country (2023-2028) & ($ millions)

Table 89. Global Nuclear Receptor ROR Gamma Sales Forecast by Type (2023-2028) & (K Pcs)

Table 90. Global Nuclear Receptor ROR Gamma Sales Market Share Forecast by Type (2023-2028)

Table 91. Global Nuclear Receptor ROR Gamma Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 92. Global Nuclear Receptor ROR Gamma Revenue Market Share Forecast by Type (2023-2028)

Table 93. Global Nuclear Receptor ROR Gamma Sales Forecast by Application (2023-2028) & (K Pcs)

Table 94. Global Nuclear Receptor ROR Gamma Sales Market Share Forecast by Application (2023-2028)

Table 95. Global Nuclear Receptor ROR Gamma Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 96. Global Nuclear Receptor ROR Gamma Revenue Market Share Forecast by Application (2023-2028)

Table 97. Genfit SA Basic Information, Nuclear Receptor ROR Gamma Manufacturing Base, Sales Area and Its Competitors

Table 98. Genfit SA Nuclear Receptor ROR Gamma Product Offered

Table 99. Genfit SA Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 100. Genfit SA Main Business

Table 101. Genfit SA Latest Developments

Table 102. GlaxoSmithKline Plc Basic Information, Nuclear Receptor ROR Gamma Manufacturing Base, Sales Area and Its Competitors

Table 103. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Product Offered

Table 104. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 105. GlaxoSmithKline Plc Main Business

Table 106. GlaxoSmithKline Plc Latest Developments

Table 107. Aurigene Discovery Technologies Basic Information, Nuclear Receptor ROR Gamma Manufacturing Base, Sales Area and Its Competitors

Table 108. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Product Offered

Table 109. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 110. Aurigene Discovery Technologies Main Business

Table 111. Aurigene Discovery Technologies Latest Developments

Table 112. Beijing Hanmi Pharmaceutical Basic Information, Nuclear Receptor ROR Gamma Manufacturing Base, Sales Area and Its Competitors

Table 113. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Product Offered

Table 114. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 115. Beijing Hanmi Pharmaceutical Main Business

Table 116. Beijing Hanmi Pharmaceutical Latest Developments

Table 117. Biogen Inc Basic Information, Nuclear Receptor ROR Gamma Manufacturing Base, Sales Area and Its Competitors

Table 118. Biogen Inc Nuclear Receptor ROR Gamma Product Offered

Table 119. Biogen Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 120. Biogen Inc Main Business

Table 121. Biogen Inc Latest Developments

Table 122. AbbVie Inc Basic Information, Nuclear Receptor ROR Gamma Manufacturing Base, Sales Area and Its Competitors

Table 123. AbbVie Inc Nuclear Receptor ROR Gamma Product Offered

Table 124. AbbVie Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 125. AbbVie Inc Main Business

Table 126. AbbVie Inc Latest Developments

Table 127. Eurofins Advinus Basic Information, Nuclear Receptor ROR Gamma Manufacturing Base, Sales Area and Its Competitors

Table 128. Eurofins Advinus Nuclear Receptor ROR Gamma Product Offered

Table 129. Eurofins Advinus Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 130. Eurofins Advinus Main Business

Table 131. Eurofins Advinus Latest Developments

Table 132. Brickell Biotech Inc Basic Information, Nuclear Receptor ROR Gamma Manufacturing Base, Sales Area and Its Competitors

Table 133. Brickell Biotech Inc Nuclear Receptor ROR Gamma Product Offered

Table 134. Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 135. Brickell Biotech Inc Main Business

Table 136. Brickell Biotech Inc Latest Developments

Table 137. Pfizer Inc Basic Information, Nuclear Receptor ROR Gamma Manufacturing Base, Sales Area and Its Competitors

Table 138. Pfizer Inc Nuclear Receptor ROR Gamma Product Offered

Table 139. Pfizer Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 140. Pfizer Inc Main Business

Table 141. Pfizer Inc Latest Developments

Table 142. Phenex Pharmaceuticals AG Basic Information, Nuclear Receptor ROR Gamma Manufacturing Base, Sales Area and Its Competitors

Table 143. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Product Offered

Table 144. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 145. Phenex Pharmaceuticals AG Main Business

Table 146. Phenex Pharmaceuticals AG Latest Developments

Table 147. Reata Pharmaceuticals Inc Basic Information, Nuclear Receptor ROR Gamma Manufacturing Base, Sales Area and Its Competitors

Table 148. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Product Offered

Table 149. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 150. Reata Pharmaceuticals Inc Main Business

Table 151. Reata Pharmaceuticals Inc Latest Developments

Table 152. Bristol-Myers Squibb Company Basic Information, Nuclear Receptor ROR Gamma Manufacturing Base, Sales Area and Its Competitors

Table 153. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Product Offered

Table 154. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 155. Bristol-Myers Squibb Company Main Business

Table 156. Bristol-Myers Squibb Company Latest Developments

Table 157. Celgene Corp Basic Information, Nuclear Receptor ROR Gamma Manufacturing Base, Sales Area and Its Competitors

Table 158. Celgene Corp Nuclear Receptor ROR Gamma Product Offered

Table 159. Celgene Corp Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 160. Celgene Corp Main Business

Table 161. Celgene Corp Latest Developments

Table 162. Eli Lilly Basic Information, Nuclear Receptor ROR Gamma Manufacturing Base, Sales Area and Its Competitors

Table 163. Eli Lilly Nuclear Receptor ROR Gamma Product Offered

Table 164. Eli Lilly Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 165. Eli Lilly Main Business

Table 166. Eli Lilly Latest Developments

Table 167. Glenmark Pharmaceuticals Basic Information, Nuclear Receptor ROR Gamma Manufacturing Base, Sales Area and Its Competitors

Table 168. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Product Offered

Table 169. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 170. Glenmark Pharmaceuticals Main Business

Table 171. Glenmark Pharmaceuticals Latest Developments

Table 172. Lead Pharma Holding BV Basic Information, Nuclear Receptor ROR Gamma Manufacturing Base, Sales Area and Its Competitors

Table 173. Lead Pharma Holding BV Nuclear Receptor ROR Gamma Product Offered

Table 174. Lead Pharma Holding BV Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 175. Lead Pharma Holding BV Main Business

Table 176. Lead Pharma Holding BV Latest Developments

List of Figures

Figure 1. Picture of Nuclear Receptor ROR Gamma

Figure 2. Nuclear Receptor ROR Gamma Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Nuclear Receptor ROR Gamma Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Nuclear Receptor ROR Gamma Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Nuclear Receptor ROR Gamma Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of BBI-6000

Figure 10. Product Picture of GRC-39815Action

Figure 11. Product Picture of R&D Progress

Figure 12. Product Picture of GSK-2981278

Figure 13. Product Picture of IMU-366

Figure 14. Product Picture of INV-17

Figure 15. Product Picture of Others

Figure 16. Global Nuclear Receptor ROR Gamma Sales Market Share by Type in 2021

Figure 17. Global Nuclear Receptor ROR Gamma Revenue Market Share by Type (2017-2022)

Figure 18. Nuclear Receptor ROR Gamma Consumed in Chronic Obstructive Pulmonary Disease

Figure 19. Global Nuclear Receptor ROR Gamma Market: Chronic Obstructive Pulmonary Disease (2017-2022) & (K Pcs)

Figure 20. Nuclear Receptor ROR Gamma Consumed in Asthma

Figure 21. Global Nuclear Receptor ROR Gamma Market: Asthma (2017-2022) & (K Pcs)

Figure 22. Nuclear Receptor ROR Gamma Consumed in Axial Spondyloarthritis

Figure 23. Global Nuclear Receptor ROR Gamma Market: Axial Spondyloarthritis (2017-2022) & (K Pcs)

Figure 24. Nuclear Receptor ROR Gamma Consumed in Breast Cancer

Figure 25. Global Nuclear Receptor ROR Gamma Market: Breast Cancer (2017-2022) & (K Pcs)

Figure 26. Nuclear Receptor ROR Gamma Consumed in Others

Figure 27. Global Nuclear Receptor ROR Gamma Market: Others (2017-2022) & (K Pcs)

Figure 28. Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2017-2022)

Figure 29. Global Nuclear Receptor ROR Gamma Revenue Market Share by Application in 2021

Figure 30. Nuclear Receptor ROR Gamma Revenue Market by Company in 2021 ($ Million)

Figure 31. Global Nuclear Receptor ROR Gamma Revenue Market Share by Company in 2021

Figure 32. Global Nuclear Receptor ROR Gamma Sales Market Share by Geographic Region (2017-2022)

Figure 33. Global Nuclear Receptor ROR Gamma Revenue Market Share by Geographic Region in 2021

Figure 34. Global Nuclear Receptor ROR Gamma Sales Market Share by Region (2017-2022)

Figure 35. Global Nuclear Receptor ROR Gamma Revenue Market Share by Country/Region in 2021

Figure 36. Americas Nuclear Receptor ROR Gamma Sales 2017-2022 (K Pcs)

Figure 37. Americas Nuclear Receptor ROR Gamma Revenue 2017-2022 ($ Millions)

Figure 38. APAC Nuclear Receptor ROR Gamma Sales 2017-2022 (K Pcs)

Figure 39. APAC Nuclear Receptor ROR Gamma Revenue 2017-2022 ($ Millions)

Figure 40. Europe Nuclear Receptor ROR Gamma Sales 2017-2022 (K Pcs)

Figure 41. Europe Nuclear Receptor ROR Gamma Revenue 2017-2022 ($ Millions)

Figure 42. Middle East & Africa Nuclear Receptor ROR Gamma Sales 2017-2022 (K Pcs)

Figure 43. Middle East & Africa Nuclear Receptor ROR Gamma Revenue 2017-2022 ($ Millions)

Figure 44. Americas Nuclear Receptor ROR Gamma Sales Market Share by Country in 2021

Figure 45. Americas Nuclear Receptor ROR Gamma Revenue Market Share by Country in 2021

Figure 46. United States Nuclear Receptor ROR Gamma Revenue Growth 2017-2022 ($ Millions)

Figure 47. Canada Nuclear Receptor ROR Gamma Revenue Growth 2017-2022 ($ Millions)

Figure 48. Mexico Nuclear Receptor ROR Gamma Revenue Growth 2017-2022 ($ Millions)

Figure 49. Brazil Nuclear Receptor ROR Gamma Revenue Growth 2017-2022 ($ Millions)

Figure 50. APAC Nuclear Receptor ROR Gamma Sales Market Share by Region in 2021

Figure 51. APAC Nuclear Receptor ROR Gamma Revenue Market Share by Regions in 2021

Figure 52. China Nuclear Receptor ROR Gamma Revenue Growth 2017-2022 ($ Millions)

Figure 53. Japan Nuclear Receptor ROR Gamma Revenue Growth 2017-2022 ($ Millions)

Figure 54. South Korea Nuclear Receptor ROR Gamma Revenue Growth 2017-2022 ($ Millions)

Figure 55. Southeast Asia Nuclear Receptor ROR Gamma Revenue Growth 2017-2022 ($ Millions)

Figure 56. India Nuclear Receptor ROR Gamma Revenue Growth 2017-2022 ($ Millions)

Figure 57. Australia Nuclear Receptor ROR Gamma Revenue Growth 2017-2022 ($ Millions)

Figure 58. Europe Nuclear Receptor ROR Gamma Sales Market Share by Country in 2021

Figure 59. Europe Nuclear Receptor ROR Gamma Revenue Market Share by Country in 2021

Figure 60. Germany Nuclear Receptor ROR Gamma Revenue Growth 2017-2022 ($ Millions)

Figure 61. France Nuclear Receptor ROR Gamma Revenue Growth 2017-2022 ($ Millions)

Figure 62. UK Nuclear Receptor ROR Gamma Revenue Growth 2017-2022 ($ Millions)

Figure 63. Italy Nuclear Receptor ROR Gamma Revenue Growth 2017-2022 ($ Millions)

Figure 64. Russia Nuclear Receptor ROR Gamma Revenue Growth 2017-2022 ($ Millions)

Figure 65. Middle East & Africa Nuclear Receptor ROR Gamma Sales Market Share by Country in 2021

Figure 66. Middle East & Africa Nuclear Receptor ROR Gamma Revenue Market Share by Country in 2021

Figure 67. Egypt Nuclear Receptor ROR Gamma Revenue Growth 2017-2022 ($ Millions)

Figure 68. South Africa Nuclear Receptor ROR Gamma Revenue Growth 2017-2022 ($ Millions)

Figure 69. Israel Nuclear Receptor ROR Gamma Revenue Growth 2017-2022 ($ Millions)

Figure 70. Turkey Nuclear Receptor ROR Gamma Revenue Growth 2017-2022 ($ Millions)

Figure 71. GCC Country Nuclear Receptor ROR Gamma Revenue Growth 2017-2022 ($ Millions)

Figure 72. Manufacturing Cost Structure Analysis of Nuclear Receptor ROR Gamma in 2021

Figure 73. Manufacturing Process Analysis of Nuclear Receptor ROR Gamma

Figure 74. Industry Chain Structure of Nuclear Receptor ROR Gamma

Figure 75. Channels of Distribution

Figure 76. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390